174 related articles for article (PubMed ID: 33731262)
1. Diagnostic value of maximum signal intensity on T1-weighted MRI images for differentiating parotid gland tumours along with pathological correlation.
Wei PY; Shao C; Huan T; Wang HB; Ding ZX; Han ZJ
Clin Radiol; 2021 Jun; 76(6):472.e19-472.e25. PubMed ID: 33731262
[TBL] [Abstract][Full Text] [Related]
2. Perfusion imaging of parotid gland tumours: usefulness of arterial spin labeling for differentiating Warthin's tumours.
Kato H; Kanematsu M; Watanabe H; Kajita K; Mizuta K; Aoki M; Okuaki T
Eur Radiol; 2015 Nov; 25(11):3247-54. PubMed ID: 25921591
[TBL] [Abstract][Full Text] [Related]
3. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Assessing Parotid Gland Tumors: Correlation and Comparison with Arterial Spin Labeling Imaging.
Ma G; Xu XQ; Zhu LN; Jiang JS; Su GY; Hu H; Bu SS; Wu FY
Korean J Radiol; 2021 Feb; 22(2):243-252. PubMed ID: 32932565
[TBL] [Abstract][Full Text] [Related]
4. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
[TBL] [Abstract][Full Text] [Related]
5. Conventional, diffusion, and dynamic contrast-enhanced MRI findings for differentiating metaplastic Warthin's tumor of the parotid gland.
Jia CH; Wang SY; Li Q; Qiu JM; Kuai XP
Sci Prog; 2021; 104(2):368504211018583. PubMed ID: 34003684
[TBL] [Abstract][Full Text] [Related]
6. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
[TBL] [Abstract][Full Text] [Related]
7. Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin's tumors.
Tanaka F; Umino M; Maeda M; Nakayama R; Inoue K; Kogue R; Obara M; Sakuma H
Sci Rep; 2022 Apr; 12(1):5947. PubMed ID: 35396374
[TBL] [Abstract][Full Text] [Related]
8. Value of pre-/post-contrast-enhanced T1 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging in differentiating parotid gland tumors.
Wen B; Zhang Z; Fu K; Zhu J; Liu L; Gao E; Qi J; Zhang Y; Cheng J; Qu F; Zhu J
Eur J Radiol; 2023 May; 162():110748. PubMed ID: 36905715
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Analysis and Pathological Basis of Signal Intensity on T2-Weighted MR Images in Benign and Malignant Parotid Tumors.
Wei P; Shao C; Tian M; Wu M; Wang H; Han Z; Hu H
Cancer Manag Res; 2021; 13():5423-5431. PubMed ID: 34262350
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of pleomorphic adenoma and Warthin's tumour of the salivary gland: is long-to-short diameter ratio a useful parameter?
Miao LY; Xue H; Ge HY; Wang JR; Jia JW; Cui LG
Clin Radiol; 2015 Nov; 70(11):1212-9. PubMed ID: 26216455
[TBL] [Abstract][Full Text] [Related]
11. Influence of post-label delay time on the performance of 3D pseudo-continuous arterial spin labeling magnetic resonance imaging in the characterization of parotid gland tumors.
Hu H; Chen L; Zhu LN; Chen W; Su GY; Dou W; Bu SS; Wu FY; Xu XQ
Eur Radiol; 2022 Feb; 32(2):1087-1094. PubMed ID: 34347158
[TBL] [Abstract][Full Text] [Related]
12. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors.
Baohong W; Jing Z; Zanxia Z; Kun F; Liang L; Eryuan G; Yong Z; Fei H; Jingliang C; Jinxia Z
Eur J Radiol; 2022 Jun; 151():110265. PubMed ID: 35472650
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of diffusion-weighted MR imaging for differentiating between Warthin's tumor and oncocytoma of the parotid gland.
Kato H; Fujimoto K; Matsuo M; Mizuta K; Aoki M
Jpn J Radiol; 2017 Feb; 35(2):78-85. PubMed ID: 28074380
[TBL] [Abstract][Full Text] [Related]
14. MRI-based texture analysis to differentiate the most common parotid tumours.
Sarioglu O; Sarioglu FC; Akdogan AI; Kucuk U; Arslan IB; Cukurova I; Pekcevik Y
Clin Radiol; 2020 Nov; 75(11):877.e15-877.e23. PubMed ID: 32703544
[TBL] [Abstract][Full Text] [Related]
15. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.
Karaman CZ; Tanyeri A; Özgür R; Öztürk VS
Dentomaxillofac Radiol; 2021 May; 50(4):20200391. PubMed ID: 33237812
[TBL] [Abstract][Full Text] [Related]
16. Characteristic bright signal of parotid pleomorphic adenomas on T2-weighted MR images with pathological correlation.
Tsushima Y; Matsumoto M; Endo K; Aihara T; Nakajima T
Clin Radiol; 1994 Jul; 49(7):485-9. PubMed ID: 8088045
[TBL] [Abstract][Full Text] [Related]
17. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
18. Parotid Warthin's tumor: novel MR imaging score as diagnostic indicator.
Luna LP; Coffey W; Alvin MD; Shanechi AM; Sankaran N; Rodriguez EF; Naeem Z; Aygun N; Khan M
Clin Imaging; 2022 Jan; 81():9-14. PubMed ID: 34598007
[TBL] [Abstract][Full Text] [Related]
19. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images.
Song LL; Chen SJ; Chen W; Shi Z; Wang XD; Song LN; Chen DS
BMC Med Imaging; 2021 Mar; 21(1):54. PubMed ID: 33743615
[TBL] [Abstract][Full Text] [Related]
20. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.
Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q
Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
